Novo Nordisk Stock Quote NOV - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

108.14

Bid

107.84

Ask

108.18

Volume

61,517

107.52 Day's Range 111.38

0.00 52 Week Range 0.00

Market Cap

486.199B

Previous Close

109.90

Open

109.98

Last Trade

108.14

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

4,496,011,436

Dividend Yield

68.31%

PE Ratio

6.57

Earnings Per Share (EPS)

18.61

Revenue

232.26B

Net Profit

83.68B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novonordisk.com

Headquarters

Bagsvaerd, Dnk

Founded

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 109.90 €. Over the last year, Novo Nordisk shares have traded in a share price range of 0.00 € to 0.00 €.

Novo Nordisk currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk is 494.11 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 6.57.

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 14 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation...

Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities

Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities The initiative will launch in six cities across five continentsInterventions aim to increase...

Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 7 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation...

Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 30 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 23 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial...

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® recommended by the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
8XJAfrican Gold Limited	0.0555 € (88.14%)	50k
T5O0BIOXXMED AG	4.50 € (76.47%)	1.85k
BDDConico Ltd	0.001 € (66.67%)	1.74M
41KQuebec Rare Earth Elements Corp	0.087 € (52.63%)	535
7KOCullinan Metals Corp	0.0104 € (33.33%)	50k
D6DAGBA Group Holding Limited	1.21 € (-72.75%)	5.62k
0PV2Moovly Media Inc	0.004 € (-52.94%)	13k
VR60Victory Battery Metals Corp	0.006 € (-49.15%)	555
CNWCodon AG	0.0075 € (-40.00%)	70.75k
VAR1Varta AG	3.15 € (-39.48%)	3.78M
D7GNel ASA	0.3839 € (10.38%)	14.49M
VAR1Varta AG	3.15 € (-39.48%)	3.78M
5LA1American Lithium Corp	0.77 € (-21.47%)	3.15M
BT81PowerHouse Energy Group Plc	0.014 € (18.64%)	2.57M
3CPXiaomi Corporation	2.6375 € (-4.58%)	1.79M